06/18/2014 - 1:57pm
Canada’s Federal Court says no price-control measures for generic drug companies

Canada’s Federal Court ruled recently that the country’s Patented Medicine Prices Review Board — a federal tribunal that regulates pricing on branded medicines — could not extend price-control measures to cover generic drug companies, according to published reports.

06/18/2014 - 1:57pm
Expanding Rx’s vaccination role

As patients across North America continue to turn to their neighborhood pharmacy for vaccinations, state and provincial governments in the United States and Canada are widening the range of immunizations that can be administered by a pharmacist.

06/18/2014 - 1:57pm
Officials: Immunization rates ‘woefully low’

With public health officials calling the number of people receiving crucial immunizations woefully low, physicians and pharmacists across North America are working to get more people vaccinated.

06/18/2014 - 1:55pm
Walmart debuts new clinic concept

Walmart executives hosted a series of store tours and briefings in advance of its company shareholders meeting in June, reported DSN sister publication Retailing Today.

06/18/2014 - 12:47pm
Survey: 76% of providers, prescribers say proposed generic drug label rule would confuse patients

A survey co-released Wednesday by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that 8-in-10 healthcare providers have serious concerns about a proposed Food and Drug Administration rule on generic drug labeling.

06/17/2014 - 12:22pm
Novartis seeks FDA approval for meningitis B vaccine

Novartis on Tuesday announced that it had submitted a biologic license application to the Food and Drug Administration for marketing approval for the use of Bexsero.

06/17/2014 - 11:55am
FDA approves Lannett's codeine sulfate tablets

Lannett Co. received approval from the Food and Drug Administration for codeine sulfate tablets USP, a schedule II controlled substance, in 15 mg, 30 mg and 60 mg dosage strengths.

06/17/2014 - 9:31am
Teva reaches settlements in Nuvigil patent case

Teva has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to a patent for Teva’s wakefulness product, Nuvigil (armodafinil) tablets.

06/13/2014 - 10:09am
Moody's: New cancer drugs represent significant growth opportunity

New approaches to treating cancer are creating big growth opportunities for the pharmaceutical industry, Moody's Investors Service stated in a report released Thursday titled "Cancer Breakthroughs Bring New Options for Patients and Revenue Streams to Big Pharma."

06/13/2014 - 9:30am
Fight the Fakes anti-counterfeit medicine coalition adds 11 partners

Following the campaign's six-month anniversary, Fight the Fakes last week announced 11 new partners, bringing the total number of member organizations to 25.